Emir Gökhan Kahraman

6PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersVeterinary mycologyCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2026
Consolidative thoracic radiotherapy following first-line chemo-immunotherapy in extensive-stage small-cell lung cancer: A systematic review and meta-analysis.

|May 27, 2026
Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study.

|May 26, 2026
Leveraging the non-contrast CT component of PET/CT: an AI-driven delta-radiomics approach to monitor treatment response in metastatic breast cancer.

|Apr 03, 2026
Prognostic Impact of Cetuximab-Related Hypomagnesemia and Hypokalemia in RAS/RAF Wild-Type Colorectal Cancer: A Multicenter Study.

Halil Göksel Güzel, Derya Kıvrak Salim, Ece Ulukal Karancı

|Jan 22, 2026
Prevalence and impact of germline mutations in pancreatic ductal adenocarcinoma.

Emir Gokhan Kahraman, Halil Taskaynatan, Taha Reşid Özdemir

|Sep 19, 2025
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.

Gökhan Şahin, Esmanur Kaplan Tüzün, Halil G Güzel

Pageof 1

Frequent Collaborators

2 joint publications

Halil Göksel Güzel

2 joint publications

Hüseyin Salih Semiz

1 joint publications

Gökhan Şahin

1 joint publications

Esmanur Kaplan Tüzün